Evidence map›Paper›PMID 38639359›Full record

Observational studyJournal of the American Heart Association2024

Design, Rationale and Initial Findings From HERA-FIB on 10 222 Patients With Atrial Fibrillation Presenting to an Emergency Department Over An 11-Year Period.

Christian Salbach, Mustafa Yildirim, Hauke Hund, Moritz Biener, Matthias Müller-Hennessen, Norbert Frey, Hugo A Katus, Evangelos Giannitsis, Barbara Ruth Milles

Registry-linked trialOpen access · goldAbstract readObservational Study
In one paragraph

Observational study in Journal of the American Heart Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05995561 (Heidelberg Registry of Atrial Fibrillation), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05995561 completednot on this map

Heidelberg Registry of Atrial Fibrillation

TypeobservationalSponsorUniversity Hospital HeidelbergRan2009 to 2020Enrolled12,297ConditionsAtrial FibrillationArmsno intervention is planned.
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Type 1 and type 2 NSTEMI in atrial fibrillation: insights from the HERA-FIB registry.Clinical research in cardiology : official journal of the German Cardiac Society · 2026
    Observational
  2. Impact of venous closure systems on time to ambulation and discharge following AF ablation: a systematic review and meta-analytic review.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2025
    Review
  3. Observational
  4. Observational
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Christian SalbachDepartment of Internal Medicine III, Cardiology University Hospital of Heidelberg Heidelberg Germany.ORCID 0000-0002-1799-545X
Mustafa YildirimDepartment of Internal Medicine III, Cardiology University Hospital of Heidelberg Heidelberg Germany.
Hauke HundDepartment of Internal Medicine III, Cardiology University Hospital of Heidelberg Heidelberg Germany.
Moritz BienerDepartment of Internal Medicine III, Cardiology University Hospital of Heidelberg Heidelberg Germany.ORCID 0000-0001-6763-6538
Matthias Müller-HennessenDepartment of Internal Medicine III, Cardiology University Hospital of Heidelberg Heidelberg Germany.
Norbert FreyDepartment of Internal Medicine III, Cardiology University Hospital of Heidelberg Heidelberg Germany.ORCID 0000-0001-7611-378X
Hugo A KatusDepartment of Internal Medicine III, Cardiology University Hospital of Heidelberg Heidelberg Germany.ORCID 0000-0002-2293-2314
Evangelos GiannitsisDepartment of Internal Medicine III, Cardiology University Hospital of Heidelberg Heidelberg Germany.ORCID 0000-0002-1025-2872
Barbara Ruth MillesDepartment of Internal Medicine III, Cardiology University Hospital of Heidelberg Heidelberg Germany.ORCID 0009-0004-4602-5489
Heidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFor the majority of patients with atrial fibrillation (AF), disease management has improved in recent years. However, there are still populations underrepresented or excluded in current registries and randomized controlled trials. HERA-FIB (Heidelberg Registry of Atrial Fibrillation) was planned to assess real-world evidence for the prevalence, demographic characteristics and management of patients with the diagnosis of AF presenting consecutively to a chest pain unit. METHODS AND

resultsHERA-FIB is a retrospective, observational, single-center study on patients with a diagnosis of AF presenting to a chest pain unit from June 2009 until March 2020. This article describes the structure, governance, outcome assessment, quality and data collection processes of the registry. Additionally, characteristics of populations of special interest are described. The study consecutively enrolled 10 222 patients presenting with AF to the chest pain unit of the University Hospital of Heidelberg. Clinical parameters and patient characteristics were assessed retrospectively. Outcome parameters included rates for all-cause death, stroke, myocardial infarction and major bleedings. We were able to investigate patient cohorts of special interest such as advanced chronic kidney disease, octogenarians, and those with acute coronary syndrome who are often underrepresented in current studies and randomized controlled trials.

conclusionsHERA-FIB is one of the largest real-world single-center retrospective registries on patients with AF, which captures the era of transition from vitamin K antagonists to non-vitamin K oral anticoagulation regimens in clinical practice and offers the possibility to investigate patient populations usually underrepresented or excluded in current available randomized controlled trials and registries. REGISTRATION: URL: https://www.clinicaltrials.gov; unique identifier: NCT05995561.

Indexed as

Atrial FibrillationEmergency Service, HospitalRegistriesAgedAged, 80 and overAnticoagulantsFemaleGermanyHumansMaleMiddle AgedPrevalenceRetrospective StudiesStrokeTime FactorsAnticoagulantsatrial fibrillationnon–vitamin K oral anticoagulantreal‐world evidenceregistryvitamin K antagonist

Identifiers

PMID38639359
PMCPMC11179873
OpenAlexW4394954516

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.